Alkosign Ltd.

As of March 31, 2026, Alkosign Ltd. carries a market capitalization of 604.38M, placing it among publicly traded companies globally. Its enterprise value stands at 682.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Alkosign Ltd. has 10.79M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Alkosign Ltd. maintains a current ratio of 2.24, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 16, 2026, Alkosign Ltd.'s stock has declined approximately 20.51% over the past 52 weeks. The 50-day moving average sits at 61.05, while the 200-day moving average is 68.55.

As of March 31, 2026, Alkosign Ltd. holds 54.19M in cash and equivalents against 132.01M in total debt, resulting in a net debt position of 77.83M. Total book value stands at 282.26M, with working capital of 164.32M providing operational flexibility.

Alkosign Ltd.'s most recent stock split took place on July 11, 2025 with a 2:3 split ratio.